UPDATE : Thursday, June 21, 2018
상단여백
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit by Nam Doo-hyun 2018-06-19 11:43
Celltrion completes FDA resubmission for Trastuzumab biosimilar by Lee Han-soo 2018-06-18 17:43
Oral care probiotics research on rise by Marian Chu 2018-06-18 15:20
SCM, Toolgen to develop new stem cell treatment by Lee Han-soo 2018-06-15 15:21
NIBEC wins to stem cell regeneration patent by Lee Han-soo 2018-06-15 14:43
라인
Nature Cell suspected of manipulating stock prices by Lee Han-soo 2018-06-12 17:54
Celltrion launches new business platform by Lee Han-soo 2018-06-05 17:49
Bio group takes part in US investment conference by Lee Han-soo 2018-06-04 16:14
Nature Cell applies for P3 clinical trials by Lee Han-soo 2018-06-01 15:43
Biosimilars quickly catch up with originals in Korea by So Jae-hyeon 2018-06-01 15:37
라인
Korean biosimilar makers tap into Japan by So Jae-hyeon 2018-05-30 15:41
LG Chem launches Enbrel biosimilar in Japan by Lee Han-soo 2018-05-30 14:31
Will biotech stocks rebound on listings in H2? by So Jae-hyeon 2018-05-30 11:33
Samsung BioLogics wins FDA nod for drug manufacturing procedure by Lee Han-soo 2018-05-24 15:56
7 Korean biopharma firms dive into biosimilar market by Marian Chu 2018-05-19 08:19
라인
Celltrion posts ₩245 billion in Q1 sales thanks to biosimilar uptake by Marian Chu 2018-05-16 12:13
Will Korean bio stocks rebound as MSCI includes Celltrion, Viromed, HLB? by Marian Chu 2018-05-16 11:25
Korean biosimilar companies welcome US pro-biosimilar initiative by Lee Han-soo 2018-05-15 17:07
Biotech shares weaken on KONEX, too by Nam Doo-hyun 2018-05-15 14:02
Large pool of capital available in biotech space: US venture fund expert by Marian Chu 2018-05-11 18:10
여백
여백
여백
Back to Top